NSRXNasus Pharma Ltd. Ordinary Shares
3.840USD+3.78%Mkt Cap: 44.97M $P/E:

Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute…

Key Statistics

Company
Market Cap44.97M $
Enterprise Value38.23M $
Revenue (TTM)
Gross Profit
Net Income (TTM)-5.86M $
Revenue/Share
Last Price3.840 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees7
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA
EV/Revenue
P/S
P/B11.89
EPS (TTM)-0.72
EPS (Forward)
52W Range
1.98023% of range9.990
52W High9.990 USD
52W Low1.980 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-211.56%
ROA-117.03%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-4.92M $
CapEx (TTM)14.00K $
FCF Margin
FCF Yield-6.75%
Net Debt-4.17M $
Net Debt/EBITDA
Balance Sheet
Debt/Equity0.04
Current Ratio2.25
Quick Ratio1.98
Book Value/Sh0.3070 USD
Cash/Share0.3660 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)19.67 USD
Upside (mean)+412.2%
Target Range18.00 USD22.00 USD
$18.00+412.2% to mean$22.00
# Analysts3
Ownership
Shares Out.11.71M
Float4.84M
Insiders49.17%
Institutions18.36%
Short Interest
Short Ratio13.1d
Short % Float2.44%
Short % Out.1.37%
Shares Short160.08K
Short (prev mo.)172.14K
Technical
SMA 503.187 (+20.5%)
SMA 2004.608 (-16.7%)
Beta
S&P 52W Chg20.80%
Avg Vol (30d)14.83K
Avg Vol (10d)17.21K
Technical Indicators
RSI (14)66.5
MACD0.1304
MACD Signal0.0720
MACD Hist.+0.0584
BB Upper3.768 USD
BB Middle3.275 USD
BB Lower2.782 USD
BB Width30.11%
ATR (14)0.3046 USD
Vol Ratio (20d)2.69x